Our present study showed for the first time that the addition of WE-CN (100 μg) significantly enhanced the antitumor effect of a HER-2/neu DNA vaccine on tumor growth, resulting in a higher survival rate compared to the HER-2 DNA vaccine alone group (Figure 8). This evidence concerns the gene ERBB2 and neoplasm.